ZEAL ZEAL Network SE : Bullish and Bearish Analyst Opinions
Sentiment & Price
▼
Sentiment Gauge
0
Bull
0
Bear
0
Watch
Bull 50%
Bear 50%
Price & Sentiment
Loading chart...
Recent News
Top Views ▼
No recent news for ZEAL
No theses available
Feed
12:10
Mar 06
Mar 06
Zealand Pharma shares plunged ~33% (trading in Denmark, implies ADR impact). Their weight loss drug showed only ~10.7% loss over 42 weeks. The weight loss market is a duopoly (Novo/Lilly). To compete, a new entrant needs superior data. Zealand's data is significantly "shorter than rivals," rendering their product commercially unviable in a crowded market. SHORT. The market is pricing out the probability of this drug's success. Potential M&A target for big pharma looking for pipeline assets despite weak data.
About ZEAL Analyst Coverage
Buzzberg tracks ZEAL (ZEAL Network SE) across 2 sources. 0 bullish vs 2 bearish calls from 2 analysts. Sentiment: mixed to bearish. 2 total trade ideas tracked.